Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism LONP1 inhibitors(lon peptidase 1, mitochondrial inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bronchogenic Carcinoma | Discovery | - | 15 Jun 2023 | |
Lymphoid neoplasm | Discovery | - | 15 Jun 2023 | |
Mitochondrial Diseases | Discovery | - | 15 Jun 2023 | |
Neoplasms | Discovery | - | 15 Jun 2023 | |
Neurodegenerative Diseases | Discovery | - | 15 Jun 2023 |